Is Green Organic Dutchman (TSX:TGOD) a Steal at $2?

Green Organic Dutchman Holdings Ltd (TSX:TGOD) may be coming off a bad month, but that doesn’t mean it’s become a cheap buy.

Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

Green Organic Dutchman Holdings (TSX:TGOD) had a very bad month of September, declining around 40%. You know it’s bad when CannTrust, a company that had its licence suspended, didn’t have as big of a drop during the month. TGOD finished September at just over $2 a share, as it hit a new 52-week low.

Why have investors been down on the stock?

While investors as a whole haven’t been very excited about cannabis stocks lately, TGOD’s decline has been notably worse. And the reason it has done so much worse is that early on in the month, when the stock was trading around $3.50, we learned that Aurora Cannabis had sold its shares in TGOD at a price of just $3.

As a result, the sale flooded the market and created a huge sell-off of TGOD stock. Inevitably, what ends up happening then is that triggers even more selling, as technical indicators tell other investors to sell while stop-losses also cause more shares to be sold along the way.

It created a perfect storm for which there was no way for TGOD to pull itself out.

Has the stock become a cheap buy?

Despite the heavy selling, TGOD’s stock hasn’t been in oversold during the month. Its Relative Strength Index (RSI), which measures the stock’s gains and losses over a 14-day period, was above 30 during the whole month of September and finished the month just above the mark. Once it falls below 30, the stock is considered to be oversold.

With the stock almost oversold and at a 52-week low, it could entice investors to buy the stock at what could be perceived as a cheap price. The problem is that for the amount of revenue that the company has generated, it’s still trading at a hefty premium.

Over the last 12 months, TGOD has generated just over $7 million in sales. With a market cap of around $560 million, that means investors are paying close to 80 times sales. By comparison, Canopy Growth was trading at a price-to-sales ratio of 36 at the close of the month. It’s hard to justify TGOD being at a more significant multiple than the top pot stock in the country.

And with the company consistently producing losses, it’s hard to say that TGOD is any better than its peers in that regard.

How TGOD could rally

What could save the company is a strong quarter that shows either significant sales growth or TGOD getting close to breaking even. While the latter may seem like a long shot, the good news is that the company says that shipments it has sent to the Ontario Cannabis Store have had very good feedback, and that there’s strong demand for the company’s premium cannabis products. With TGOD finally ready to make a splash in the recreational market, it could be what it needs to pull itself out of this tailspin.

Ultimately, it’ll come down to how strong the numbers look like. Until TGOD can demonstrate some sort of progress, it’ll be hard to get investors excited about a stock that’s been in a free fall. And it may take a couple of quarters before investors are able to see just how strong those numbers really are.

Bottom line

In short, no, TGOD is still not a good buy even at $2 a share. While the company claims it is seeing some positive results, investors need to be able to see that for themselves on the company’s financials, and that’s when we might see the stock finally rally.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »